“…17,20,24–26,52,53,62,64,73,76,90,94–96 Other methodological challenges identified related to ambiguous and inaccurate patient identification, 15,45,67–70,76,85,94,96 –99 restricted generalisability due to poor geographic transferability of evidence, 16,40,42,43,52,53,60,71,85,96,98 difficulties defining comparators, 15,97 consequences of applied time horizon, 65 challenged outcome measurement 35,45,57,89,97,100 and challenges regarding a reliable preference-based outcome valuation. 37,45,58,59,66,72,84,85,87,101 –105…”